Peking University People's Hospital
794
146
167
145
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
1.9%
15 terminated/withdrawn out of 794 trials
90.6%
+4.1% vs industry average
11%
88 trials in Phase 3/4
3%
5 of 145 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (794)
Prophylactic NAC to Improve Platelet Engraftment After Haploidentical Transplantation in Severe Aplastic Anemia Patients
Role: lead
Preliminary Evaluation of a Large Language Model-Based Tool for Complex Surgical Decision Support in Lung Cancer
Role: lead
Fecal Microbiota Transplantation for Steroid-resistant or Relapsed Immune Thrombocytopenia
Role: lead
Sonrotoclax Plus Dexamethasone With or Without Daratumumab Regimen in Patients With t(11;14) Primary AL Amyloidosis
Role: lead
CBT-I for the Patients With Chronic Insomnia in China
Role: lead
Prospective Evaluation of Dynamic Serum ProGRP for Treatment Response Monitoring in Ewing Sarcoma
Role: lead
Effect of Inspired Oxygen Concentration on Postoperative Atelectasis After VATS Right Lobectomy
Role: lead
Interim PET/CT-adapted Use of PD-1 Inhibitor Combined With De-escalated Chemotherapy-AVD in Classic Hodgkin Lymphoma
Role: lead
Fluzoparib Combined With Camrelizumab for Neoadjuvant Treatment of Embryogenic BRCA Mutation HER2 Negative Breast Cancer: an Open, Single Arm, Multicenter Study
Role: lead
Sun Yat-Sen Treatment Strategy for Enhancing Response in Muscle-invasive Bladder Cancer
Role: collaborator
Orlistat Plus Progestin for Fertility-Sparing Treatment of Endometrial Cancer or Atypical Hyperplasia
Role: lead
Autologous Fecal Microbiota Transplantation for Anal Function Recovery After Ileostomy Reversal in Rectal Cancer
Role: lead
PregnAncy-Related Aortic DISsEction in China
Role: collaborator
Clinical Study of a New Treatment Model for Elderly Lung Cancer Patients
Role: lead
A Cohort Study of Combined Cryoablation and Thermal Ablation for Non-surgical Treatment of Breast Cancer Patients
Role: lead
Real-world Study of Pyrotinib-containing Regimens of Advanced HER2-positive Breast Cancer
Role: lead
CDK4/6 Inhibitors Combined With Endocrine Therapy for Neoadjuvant Treatment
Role: lead
ctDNA-Guided De-Escalation of Adjuvant Chemotherapy With Dalpiciclib in HR-Positive/HER2-Negative Breast Cancer
Role: lead
Clinical Characteristics and Mechanism Research of Deucravacitinib in the Idiopathic Inflammatory Myopathies
Role: lead
A Novel Conditioning Regimen for Haplo-HSCT in Older Patients With SAA
Role: lead